Lebanon vs Qatar: HIV-positive TB patients on ART (antiretroviral therapy)
Lebanon
100.0%
in 2024
Qatar
100.0%
in 2024
Lebanon rank
1st
Qatar rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Lebanon
- Qatar
How they compare
Lebanon currently reports 100.0% against 100.0% in Qatar, a difference of 0.0%.
Across all 9 years both countries report, Qatar has been ahead every year.
Lebanon ranks 1st and Qatar ranks 1st of 144 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lebanon | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 86.7% | 100.0% | 13.3% | Qatar |
| 2020s | 91.8% | 100.0% | 8.2% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Lebanon or Qatar?
- Lebanon, at 100.0% against 100.0% in Qatar as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Lebanon and Qatar?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Qatar?
- 9 years are reported by both, from 2007 to 2024.
- How do Lebanon and Qatar rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Lebanon ranks 1st and Qatar ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.